Aegis Capital initiated coverage on Flora Growth with a new price target
$FLGC
Biotechnology: Pharmaceutical Preparations
Health Care
Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/25/2024 | $4.00 | Buy | Aegis Capital |
| 10/13/2021 | $10.00 | Buy | Roth Capital |
| 6/23/2021 | $6.00 | Buy | MKM Partners |
4 - Flora Growth Corp. (0001790169) (Issuer)
4 - Flora Growth Corp. (0001790169) (Issuer)
4 - Flora Growth Corp. (0001790169) (Issuer)
Fort Lauderdale, Florida--(Newsfile Corp. - June 5, 2024) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") has entered into a share purchase agreement (the "Agreement") to acquire of all of the issued and outstanding shares of Australian Vaporizers Pty Limited ("Australian Vaporizers") in exchange for 550,000 Flora common shares, valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The transaction closed on June 4, 2024. Australian Vaporizers was founded in 2010 and has become one of the largest online retailers of vaporizers, hardware, and accessories in Australia. It is an online expert for aromathe
TORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. ("Aussie Vapes"), its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:FLGC) ("Flora"), a U.S.-based consumer-packaged goods and pharmaceutical distributor serving all 50 states and 28 countries. The sale was completed through a share purchase agreement (the "SPA") entered into between Lifeist, as vendor, and Flora Growth Corp, as purchaser, purs
VANCOUVER, BC, June 4, 2024 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2024-1678 CEAPRO INC. ("CZO")BULLETIN TYPE: Plan of Arrangement, Remain Halted, DelistBULLETIN DATE: June 4, 2024TSX Venture Tier 2 Company TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholder
Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00
Roth Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $10.00
MKM Partners initiated coverage of Flora Growth with a rating of Buy and set a new price target of $6.00
4 - Flora Growth Corp. (0001790169) (Issuer)
4 - Flora Growth Corp. (0001790169) (Issuer)
4 - Flora Growth Corp. (0001790169) (Issuer)